Log In
Bookmark This Page | Make This Your Homepage | Enlarge Text Size

E-mail this article to a friend  Download this article in PDF format

AAOS adopts CTS clinical treatment guidelines

By Fareeha Shuttari-Khan, MPH

During its September meeting, the AAOS Board of Directors adopted a new clinical practice guideline on the treatment of carpal tunnel syndrome (CTS). Kristy L. Weber, MD, chair of the Council on Research, Quality Assessment and Technology, presented the guidelines, which were developed by a workgroup appointed by the Guidelines and Technology Oversight Committee.

The Guideline Workgroup on the treatment of CTS was chaired by Michael W. Keith, MD, and cochair Victoria Masear, MD. Members of the workgroup included Kevin Chung, MD; Peter C Amadio, MD; Michael Andary, MD; Richard W. Barth, MD; B. Kent Maupin, MD; and Brent Graham, MD. William C. Watters III, MD, is chair of the AAOS Guidelines and Technology Oversight Committee.

Under the new AAOS clinical guidelines on the treatment of carpal tunnel syndrome, early surgery is an option when clinical evidence of median nerve denervation exists. Courtesy of Keith A. Segalman, MD

In May 2007, the Board adopted the first two clinical practice guidelines—on the prevention of symptomatic pulmonary embolism in patients undergoing total hip or total knee arthroplasty and on the diagnosis of CTS (see AAOS Now July 2007 issue).

The summary of recommendations for the treatment of CTS can be found on below. All three complete guidelines and supporting documentation are available on the AAOS Web site at www.aaos.org/guidelines

Fareeha Shuttari-Khan, MPH, is the evidence-based medicine coordinator in the AAOS research department.

AAOS Now
October 2008 Issue
http://www.aaos.org/news/aaosnow/oct08/cover1.asp

Patient Information